Ascletis Inc
Major Drugs - Chapel Hill, NC, US
Ascletis Inc Details
Ascletis is an innovative R&D driven biotech listed on Hong Kong Stock Exchange (1672.HK). Ascletis is committed to developing and commercializing innovative drugs in the areas of NASH, cancer lipid metabolism and oral checkpoint inhibitors, viral hepatitis and HIV/AIDS for unmet medical needs in China and globally. Led by a management team with deep expertise and a proven track record, Ascletis has developed into a fully integrated platform covering the entire value chain from discovery and development to manufacturing and commercialization.Gannex, a wholly-owned company of Ascletis, is fully dedicated to the R&D and commercialization of new drugs in the field of NASH. Gannex has three clinical stage drug candidates against three different targets – FASN, THR-beta and FXR, and three combination therapies.
Ascletis Inc Technologies
Load Balancers
Apache
SSL Certificates
OpenSSL
Advertising Networks
Baidu Ads
CSS and JavaScript Libraries
Bootstrap Framework
Online Video Platforms
JW Player
Other
Mobile Friendly